TickerFacts.

Jupiter Neurosciences, Inc. (JUNS): Revenue

Annual figures by period end, from SEC filings.

$21.8K
Year ended 2025-12-31
2024-12-31: $02025-12-31: $21.8K$21.8K
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$21.8Kn/a2026-04-01, From 2025-01-01
2024-12-31$0n/a2026-04-01, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$21.8Kn/a
Skinvisible, Inc. (SKVI)2025-12-31$20.0K0.0%
Bioadaptives, Inc. (BDPT)2025-12-31$18.3K+44.3%
PRF Technologies Ltd. (PRFX)2025-12-31$17.0Kn/a
Talphera, Inc. (TLPH)2025-12-31$28.0Kn/a
Impact Biomedical Inc. (IBO)2025-12-31$32.0Kn/a
Lyell Immunopharma, Inc. (LYEL)2025-12-31$36.0K-41.0%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$40.0K-51.8%
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%

Compare JUNS, SKVI, BDPT, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗